WO1999034772A1 - Produits solides et procedes pour la remineralisation des dents et la prevention de leur demineralisation - Google Patents
Produits solides et procedes pour la remineralisation des dents et la prevention de leur demineralisation Download PDFInfo
- Publication number
- WO1999034772A1 WO1999034772A1 PCT/US1998/024529 US9824529W WO9934772A1 WO 1999034772 A1 WO1999034772 A1 WO 1999034772A1 US 9824529 W US9824529 W US 9824529W WO 9934772 A1 WO9934772 A1 WO 9934772A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- calcium
- water
- product
- salt
- phosphate
- Prior art date
Links
- 239000012265 solid product Substances 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims description 66
- 238000005115 demineralization Methods 0.000 title description 12
- 230000002328 demineralizing effect Effects 0.000 title description 12
- 230000002265 prevention Effects 0.000 title description 5
- 239000000047 product Substances 0.000 claims abstract description 106
- 239000011575 calcium Substances 0.000 claims abstract description 75
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 75
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 59
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 51
- 210000003296 saliva Anatomy 0.000 claims abstract description 51
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims abstract description 50
- 210000004268 dentin Anatomy 0.000 claims abstract description 35
- 230000003902 lesion Effects 0.000 claims abstract description 34
- 241000628997 Flos Species 0.000 claims abstract description 32
- 125000002091 cationic group Chemical group 0.000 claims abstract description 31
- 239000000758 substrate Substances 0.000 claims abstract description 31
- 210000005239 tubule Anatomy 0.000 claims abstract description 29
- 230000000395 remineralizing effect Effects 0.000 claims abstract description 28
- 239000007787 solid Substances 0.000 claims abstract description 26
- 125000000129 anionic group Chemical group 0.000 claims abstract description 25
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 21
- 239000002244 precipitate Substances 0.000 claims abstract description 20
- 230000001089 mineralizing effect Effects 0.000 claims abstract description 15
- 244000153158 Ammi visnaga Species 0.000 claims abstract description 9
- 235000010585 Ammi visnaga Nutrition 0.000 claims abstract description 9
- 239000003479 dental cement Substances 0.000 claims abstract description 9
- 239000004053 dental implant Substances 0.000 claims abstract description 7
- -1 fluoride anions Chemical class 0.000 claims description 78
- 229960005069 calcium Drugs 0.000 claims description 72
- 239000000203 mixture Substances 0.000 claims description 63
- 238000000576 coating method Methods 0.000 claims description 57
- 150000003839 salts Chemical class 0.000 claims description 55
- 239000011248 coating agent Substances 0.000 claims description 54
- 229910019142 PO4 Inorganic materials 0.000 claims description 38
- 239000010452 phosphate Substances 0.000 claims description 37
- 229910052751 metal Inorganic materials 0.000 claims description 34
- 239000002184 metal Substances 0.000 claims description 34
- 239000001993 wax Substances 0.000 claims description 32
- 229920000642 polymer Polymers 0.000 claims description 16
- 150000001768 cations Chemical class 0.000 claims description 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 9
- 244000215068 Acacia senegal Species 0.000 claims description 7
- 229920000084 Gum arabic Polymers 0.000 claims description 7
- 235000010489 acacia gum Nutrition 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 231100000252 nontoxic Toxicity 0.000 claims description 7
- 230000003000 nontoxic effect Effects 0.000 claims description 7
- 235000011007 phosphoric acid Nutrition 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 6
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 6
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229910052712 strontium Inorganic materials 0.000 claims description 6
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 6
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 239000012188 paraffin wax Substances 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 229920001897 terpolymer Polymers 0.000 claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- 241000416162 Astragalus gummifer Species 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 229920002261 Corn starch Polymers 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- 229920001615 Tragacanth Polymers 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000205 acacia gum Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 235000013871 bee wax Nutrition 0.000 claims description 4
- 239000012166 beeswax Substances 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 229960002713 calcium chloride Drugs 0.000 claims description 4
- 235000011148 calcium chloride Nutrition 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000008120 corn starch Substances 0.000 claims description 4
- 229920001451 polypropylene glycol Polymers 0.000 claims description 4
- 229910052718 tin Inorganic materials 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 3
- 235000006491 Acacia senegal Nutrition 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- 229920004934 Dacron® Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920005682 EO-PO block copolymer Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 3
- 229920000297 Rayon Polymers 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 235000011054 acetic acid Nutrition 0.000 claims description 3
- 150000001447 alkali salts Chemical class 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 3
- 239000001639 calcium acetate Substances 0.000 claims description 3
- 235000011092 calcium acetate Nutrition 0.000 claims description 3
- 229960005147 calcium acetate Drugs 0.000 claims description 3
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims description 3
- 239000004227 calcium gluconate Substances 0.000 claims description 3
- 235000013927 calcium gluconate Nutrition 0.000 claims description 3
- 229960004494 calcium gluconate Drugs 0.000 claims description 3
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 3
- 229940095618 calcium glycerophosphate Drugs 0.000 claims description 3
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 3
- 229910010293 ceramic material Inorganic materials 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- TVFJAZCVMOXQRK-UHFFFAOYSA-N ethenyl 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC(=O)OC=C TVFJAZCVMOXQRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 150000003951 lactams Chemical class 0.000 claims description 3
- 239000011976 maleic acid Substances 0.000 claims description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 3
- 235000019691 monocalcium phosphate Nutrition 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 239000002243 precursor Substances 0.000 claims description 3
- 239000002964 rayon Substances 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 210000002268 wool Anatomy 0.000 claims description 3
- 239000004200 microcrystalline wax Substances 0.000 claims description 2
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 238000007334 copolymerization reaction Methods 0.000 claims 2
- 230000001804 emulsifying effect Effects 0.000 claims 2
- 229920000728 polyester Polymers 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract description 39
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract description 23
- 239000001506 calcium phosphate Substances 0.000 abstract description 20
- 235000011010 calcium phosphates Nutrition 0.000 abstract description 18
- 239000000243 solution Substances 0.000 description 47
- 235000021317 phosphate Nutrition 0.000 description 37
- 229940091249 fluoride supplement Drugs 0.000 description 33
- 239000000463 material Substances 0.000 description 28
- 210000003298 dental enamel Anatomy 0.000 description 24
- 239000002245 particle Substances 0.000 description 24
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 19
- 150000002500 ions Chemical class 0.000 description 18
- 208000002925 dental caries Diseases 0.000 description 15
- 238000001556 precipitation Methods 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 150000004673 fluoride salts Chemical class 0.000 description 13
- 150000001450 anions Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000005755 formation reaction Methods 0.000 description 12
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 12
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 11
- 229910001424 calcium ion Inorganic materials 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 10
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 10
- 230000033558 biomineral tissue development Effects 0.000 description 9
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920002292 Nylon 6 Polymers 0.000 description 5
- 240000002834 Paulownia tomentosa Species 0.000 description 5
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 229920001477 hydrophilic polymer Polymers 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000000606 toothpaste Substances 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 4
- 229940095672 calcium sulfate Drugs 0.000 description 4
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium phosphate dihydrate Substances O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000013265 extended release Methods 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 4
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 239000011118 polyvinyl acetate Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- DHEQXMRUPNDRPG-UHFFFAOYSA-N strontium nitrate Chemical compound [Sr+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O DHEQXMRUPNDRPG-UHFFFAOYSA-N 0.000 description 4
- 229920003176 water-insoluble polymer Polymers 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 229910052586 apatite Inorganic materials 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000005323 carbonate salts Chemical class 0.000 description 3
- 230000001013 cariogenic effect Effects 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 239000007888 film coating Substances 0.000 description 3
- 238000009501 film coating Methods 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 238000010944 pre-mature reactiony Methods 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 230000002821 anti-nucleating effect Effects 0.000 description 2
- 229940092738 beeswax Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- 229920001688 coating polymer Polymers 0.000 description 2
- 239000008119 colloidal silica Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 239000008393 encapsulating agent Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229960002337 magnesium chloride Drugs 0.000 description 2
- 235000011147 magnesium chloride Nutrition 0.000 description 2
- 150000002681 magnesium compounds Chemical class 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 229910001631 strontium chloride Inorganic materials 0.000 description 2
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 2
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Chemical compound [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 description 2
- UBXAKNTVXQMEAG-UHFFFAOYSA-L strontium sulfate Chemical compound [Sr+2].[O-]S([O-])(=O)=O UBXAKNTVXQMEAG-UHFFFAOYSA-L 0.000 description 2
- RXSHXLOMRZJCLB-UHFFFAOYSA-L strontium;diacetate Chemical compound [Sr+2].CC([O-])=O.CC([O-])=O RXSHXLOMRZJCLB-UHFFFAOYSA-L 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 150000003606 tin compounds Chemical class 0.000 description 2
- ZSUXOVNWDZTCFN-UHFFFAOYSA-L tin(ii) bromide Chemical compound Br[Sn]Br ZSUXOVNWDZTCFN-UHFFFAOYSA-L 0.000 description 2
- JTDNNCYXCFHBGG-UHFFFAOYSA-L tin(ii) iodide Chemical compound I[Sn]I JTDNNCYXCFHBGG-UHFFFAOYSA-L 0.000 description 2
- QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(ii) oxide Chemical compound [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 150000003752 zinc compounds Chemical class 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- YXTDAZMTQFUZHK-ZVGUSBNCSA-L (2r,3r)-2,3-dihydroxybutanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O YXTDAZMTQFUZHK-ZVGUSBNCSA-L 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- CKUJRAYMVVJDMG-IYEMJOQQSA-L (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;tin(2+) Chemical compound [Sn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O CKUJRAYMVVJDMG-IYEMJOQQSA-L 0.000 description 1
- VSKCCZIUZNTICH-ZPYUXNTASA-N (e)-but-2-enoic acid;ethenyl acetate Chemical compound C\C=C\C(O)=O.CC(=O)OC=C VSKCCZIUZNTICH-ZPYUXNTASA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical class FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- TXNFKHHYTGEPRL-UHFFFAOYSA-N 1-[4-(trifluoromethylsulfanyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=C(SC(F)(F)F)C=C1 TXNFKHHYTGEPRL-UHFFFAOYSA-N 0.000 description 1
- RMSOEGBYNWXXBG-UHFFFAOYSA-N 1-chloronaphthalen-2-ol Chemical compound C1=CC=CC2=C(Cl)C(O)=CC=C21 RMSOEGBYNWXXBG-UHFFFAOYSA-N 0.000 description 1
- NMGPHUOPSWFUEB-UHFFFAOYSA-N 2-(butylamino)ethyl 2-methylprop-2-enoate Chemical compound CCCCNCCOC(=O)C(C)=C NMGPHUOPSWFUEB-UHFFFAOYSA-N 0.000 description 1
- GEZAUFNYMZVOFV-UHFFFAOYSA-J 2-[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetan-2-yl)oxy]-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetane 2-oxide Chemical compound [Sn+2].[Sn+2].[O-]P([O-])(=O)OP([O-])([O-])=O GEZAUFNYMZVOFV-UHFFFAOYSA-J 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- GLULCKCBVYGUDD-UHFFFAOYSA-N 2-phosphonobutane-1,1,1-tricarboxylic acid Chemical compound CCC(P(O)(O)=O)C(C(O)=O)(C(O)=O)C(O)=O GLULCKCBVYGUDD-UHFFFAOYSA-N 0.000 description 1
- USYAMXSCYLGBPT-UHFFFAOYSA-L 3-carboxy-3-hydroxypentanedioate;tin(2+) Chemical compound [Sn+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O USYAMXSCYLGBPT-UHFFFAOYSA-L 0.000 description 1
- JKTORXLUQLQJCM-UHFFFAOYSA-N 4-phosphonobutylphosphonic acid Chemical compound OP(O)(=O)CCCCP(O)(O)=O JKTORXLUQLQJCM-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229940120146 EDTMP Drugs 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 206010016818 Fluorosis Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- HASPLXMDQRLCJM-UHFFFAOYSA-M S(=O)(=O)([O-])[O-].[NH4+].[Sr+] Chemical compound S(=O)(=O)([O-])[O-].[NH4+].[Sr+] HASPLXMDQRLCJM-UHFFFAOYSA-M 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LCXXNKZQVOXMEH-UHFFFAOYSA-N Tetrahydrofurfuryl methacrylate Chemical compound CC(=C)C(=O)OCC1CCCO1 LCXXNKZQVOXMEH-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- UGLUPDDGTQHFKU-UHFFFAOYSA-M [NH4+].S(=O)(=O)([O-])[O-].[Mg+] Chemical compound [NH4+].S(=O)(=O)([O-])[O-].[Mg+] UGLUPDDGTQHFKU-UHFFFAOYSA-M 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-ASMJPISFSA-N alpha-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940095564 anhydrous calcium sulfate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- GUPPESBEIQALOS-UHFFFAOYSA-L calcium tartrate Chemical compound [Ca+2].[O-]C(=O)C(O)C(O)C([O-])=O GUPPESBEIQALOS-UHFFFAOYSA-L 0.000 description 1
- 235000011035 calcium tartrate Nutrition 0.000 description 1
- 239000001427 calcium tartrate Substances 0.000 description 1
- PBUBJNYXWIDFMU-UHFFFAOYSA-L calcium;butanedioate Chemical compound [Ca+2].[O-]C(=O)CCC([O-])=O PBUBJNYXWIDFMU-UHFFFAOYSA-L 0.000 description 1
- KBQXDPRNSDVNLB-UHFFFAOYSA-L calcium;carbonic acid;hydrogen phosphate Chemical compound [Ca+2].OC(O)=O.OP([O-])([O-])=O KBQXDPRNSDVNLB-UHFFFAOYSA-L 0.000 description 1
- MFLAROGHONQVRM-UHFFFAOYSA-L calcium;dihydrogen phosphate;fluoride Chemical compound [F-].[Ca+2].OP(O)([O-])=O MFLAROGHONQVRM-UHFFFAOYSA-L 0.000 description 1
- MLMODXBPCNLAGP-UHFFFAOYSA-L calcium;propanedioate Chemical compound [Ca+2].[O-]C(=O)CC([O-])=O MLMODXBPCNLAGP-UHFFFAOYSA-L 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 208000004042 dental fluorosis Diseases 0.000 description 1
- 229940023487 dental product Drugs 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- PNOXNTGLSKTMQO-UHFFFAOYSA-L diacetyloxytin Chemical compound CC(=O)O[Sn]OC(C)=O PNOXNTGLSKTMQO-UHFFFAOYSA-L 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- SAEOCANGOMBQSP-UHFFFAOYSA-N diazanium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [NH4+].[NH4+].[O-]P([O-])(F)=O SAEOCANGOMBQSP-UHFFFAOYSA-N 0.000 description 1
- TXGQALXWGNPMKD-UHFFFAOYSA-L diazanium;zinc;disulfate;hexahydrate Chemical compound [NH4+].[NH4+].O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O TXGQALXWGNPMKD-UHFFFAOYSA-L 0.000 description 1
- SXWUDUINABFBMK-UHFFFAOYSA-L dilithium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Li+].[Li+].[O-]P([O-])(F)=O SXWUDUINABFBMK-UHFFFAOYSA-L 0.000 description 1
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- QGKBPWOLFJRLKE-UHFFFAOYSA-J distrontium;phosphonato phosphate Chemical compound [Sr+2].[Sr+2].[O-]P([O-])(=O)OP([O-])([O-])=O QGKBPWOLFJRLKE-UHFFFAOYSA-J 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- PJJZFXPJNUVBMR-UHFFFAOYSA-L magnesium benzoate Chemical compound [Mg+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 PJJZFXPJNUVBMR-UHFFFAOYSA-L 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- CQQJGTPWCKCEOQ-UHFFFAOYSA-L magnesium dipropionate Chemical compound [Mg+2].CCC([O-])=O.CCC([O-])=O CQQJGTPWCKCEOQ-UHFFFAOYSA-L 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 239000011742 magnesium glycerophosphate Substances 0.000 description 1
- 235000001130 magnesium glycerophosphate Nutrition 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 235000012254 magnesium hydroxide Nutrition 0.000 description 1
- BLQJIBCZHWBKSL-UHFFFAOYSA-L magnesium iodide Chemical compound [Mg+2].[I-].[I-] BLQJIBCZHWBKSL-UHFFFAOYSA-L 0.000 description 1
- 229910001641 magnesium iodide Inorganic materials 0.000 description 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229940095060 magnesium tartrate Drugs 0.000 description 1
- OVGXLJDWSLQDRT-JCWNAWFTSA-L magnesium;(2r)-2-hydroxypropanoate Chemical compound [Mg+2].C[C@@H](O)C([O-])=O.C[C@@H](O)C([O-])=O OVGXLJDWSLQDRT-JCWNAWFTSA-L 0.000 description 1
- MUZDLCBWNVUYIR-ZVGUSBNCSA-L magnesium;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Mg+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O MUZDLCBWNVUYIR-ZVGUSBNCSA-L 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- BHJKUVVFSKEBEX-UHFFFAOYSA-L magnesium;2,3-dihydroxypropyl phosphate Chemical compound [Mg+2].OCC(O)COP([O-])([O-])=O BHJKUVVFSKEBEX-UHFFFAOYSA-L 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DBJLJFTWODWSOF-UHFFFAOYSA-L nickel(ii) fluoride Chemical compound F[Ni]F DBJLJFTWODWSOF-UHFFFAOYSA-L 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- BHZSLLSDZFAPFH-UHFFFAOYSA-L palladium(2+);difluoride Chemical compound F[Pd]F BHZSLLSDZFAPFH-UHFFFAOYSA-L 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940044652 phenolsulfonate Drugs 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- CKRORYDHXIRZCH-UHFFFAOYSA-N phosphoric acid;dihydrate Chemical compound O.O.OP(O)(O)=O CKRORYDHXIRZCH-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 229940108184 stannous iodide Drugs 0.000 description 1
- RCIVOBGSMSSVTR-UHFFFAOYSA-L stannous sulfate Chemical compound [SnH2+2].[O-]S([O-])(=O)=O RCIVOBGSMSSVTR-UHFFFAOYSA-L 0.000 description 1
- 229940007163 stannous tartrate Drugs 0.000 description 1
- YJPVTCSBVRMESK-UHFFFAOYSA-L strontium bromide Chemical compound [Br-].[Br-].[Sr+2] YJPVTCSBVRMESK-UHFFFAOYSA-L 0.000 description 1
- 229910001625 strontium bromide Inorganic materials 0.000 description 1
- 229940074155 strontium bromide Drugs 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- 150000003438 strontium compounds Chemical class 0.000 description 1
- UUCCCPNEFXQJEL-UHFFFAOYSA-L strontium dihydroxide Chemical compound [OH-].[OH-].[Sr+2] UUCCCPNEFXQJEL-UHFFFAOYSA-L 0.000 description 1
- 229910001866 strontium hydroxide Inorganic materials 0.000 description 1
- KRIJWFBRWPCESA-UHFFFAOYSA-L strontium iodide Chemical compound [Sr+2].[I-].[I-] KRIJWFBRWPCESA-UHFFFAOYSA-L 0.000 description 1
- 229910001643 strontium iodide Inorganic materials 0.000 description 1
- QRVYVKGHSWMAJI-IYEMJOQQSA-L strontium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Sr+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O QRVYVKGHSWMAJI-IYEMJOQQSA-L 0.000 description 1
- IUMOPUXDPFMEMV-UHFFFAOYSA-L strontium;2,3-dihydroxybutanedioate Chemical compound [Sr+2].[O-]C(=O)C(O)C(O)C([O-])=O IUMOPUXDPFMEMV-UHFFFAOYSA-L 0.000 description 1
- CCUZKVDGQHXAFK-UHFFFAOYSA-L strontium;2-hydroxypropanoate Chemical compound [Sr+2].CC(O)C([O-])=O.CC(O)C([O-])=O CCUZKVDGQHXAFK-UHFFFAOYSA-L 0.000 description 1
- RDRLLHKVJZUFIB-UHFFFAOYSA-L strontium;dibenzoate Chemical compound [Sr+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 RDRLLHKVJZUFIB-UHFFFAOYSA-L 0.000 description 1
- YQZLOQWDIAWFTG-UHFFFAOYSA-L strontium;octanoate Chemical compound [Sr+2].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O YQZLOQWDIAWFTG-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- FSBZGYYPMXSIEE-UHFFFAOYSA-H tin(2+);diphosphate Chemical compound [Sn+2].[Sn+2].[Sn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O FSBZGYYPMXSIEE-UHFFFAOYSA-H 0.000 description 1
- CVNKFOIOZXAFBO-UHFFFAOYSA-J tin(4+);tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Sn+4] CVNKFOIOZXAFBO-UHFFFAOYSA-J 0.000 description 1
- 229910000375 tin(II) sulfate Inorganic materials 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- NFMWFGXCDDYTEG-UHFFFAOYSA-N trimagnesium;diborate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]B([O-])[O-].[O-]B([O-])[O-] NFMWFGXCDDYTEG-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- QGAPCDHPGCYAKM-UHFFFAOYSA-H tristrontium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Sr+2].[Sr+2].[Sr+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QGAPCDHPGCYAKM-UHFFFAOYSA-H 0.000 description 1
- LNSYCBFBTCINRL-UHFFFAOYSA-N tristrontium;diborate Chemical compound [Sr+2].[Sr+2].[Sr+2].[O-]B([O-])[O-].[O-]B([O-])[O-] LNSYCBFBTCINRL-UHFFFAOYSA-N 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- BIKXLKXABVUSMH-UHFFFAOYSA-N trizinc;diborate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]B([O-])[O-].[O-]B([O-])[O-] BIKXLKXABVUSMH-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- OMSYGYSPFZQFFP-UHFFFAOYSA-J zinc pyrophosphate Chemical compound [Zn+2].[Zn+2].[O-]P([O-])(=O)OP([O-])([O-])=O OMSYGYSPFZQFFP-UHFFFAOYSA-J 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- XLMCDAMBOROREP-UHFFFAOYSA-N zinc;3-phosphonooxypropane-1,2-diolate Chemical compound [Zn+2].OP(O)(=O)OCC([O-])C[O-] XLMCDAMBOROREP-UHFFFAOYSA-N 0.000 description 1
- JDLYKQWJXAQNNS-UHFFFAOYSA-L zinc;dibenzoate Chemical compound [Zn+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 JDLYKQWJXAQNNS-UHFFFAOYSA-L 0.000 description 1
- XDWXRAYGALQIFG-UHFFFAOYSA-L zinc;propanoate Chemical compound [Zn+2].CCC([O-])=O.CCC([O-])=O XDWXRAYGALQIFG-UHFFFAOYSA-L 0.000 description 1
- OMQSJNWFFJOIMO-UHFFFAOYSA-J zirconium tetrafluoride Chemical compound F[Zr](F)(F)F OMQSJNWFFJOIMO-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Definitions
- the present invention relates to improved solid products and methods for remineralizing subsurface lesions in teeth and for mineralizing exposed tubules in dentin to prevent demineralization thereof. More particularly, the present invention relates to solid products having a solid substrate containing remineralization salts such as calcium salts and phosphate salts to be applied to lesions in dental enamel to remineralize the lesions in teeth and/or to mineralize exposed tubules in dentin, and to methods of using such solid products.
- remineralization salts such as calcium salts and phosphate salts
- the primary component of enamel and dentin in teeth is calcium phosphate in the form of calcium hydroxyapatite. While highly insoluble at normal oral pHs, the calcium phosphate in the teeth tends to be relatively soluble in acidic media. Consequently, carious lesions can form in the subsurface of a tooth when such tooth is exposed to acids formed from the glycolysis of sugars caused by various oral bacteria.
- saliva helps protect teeth against demineralization and can slowly remineralize teeth which have become demineralized by acids. It is well known that the presence of fluoride ions can enhance the natural remineralization process and this is one of the accepted mechanisms by which fluoride toothpastes and rinses protect against caries. However, the efficacy of fluoride-containing toothpastes and rinses to remineralize teeth is limited by the modest levels of calcium and phosphate in saliva. It is evident from the art that it is highly desirable to increase the available concentration of calcium and phosphate ions in the oral cavity to speed up the remineralization process.
- U.S. Patent No. 4,080,440 discloses a metastable solution of calcium and phosphate ions at a low pH (between 2.5 and 4.0) under which conditions the solubility of calcium phosphate salts is high. After penetration of the solution into demineralized enamel, remineralization results from the precipitation of calcium phosphate salts when the pH rises. Fluoride ions can be included in the metastable solution.
- a significant disadvantage of the use of metastable solutions is that the relatively low pH might demineralize the dental enamel and/or injure other tissue.
- U.S. Patent Nos. 4,177,258, 4,183,915 and 4,348,381 disclose a remineralizing solution containing supersaturated concentrations of calcium ions, phosphate ions and a fluoride source stabilized by the presence of an antinucleating agent such as diamine tetramethylenephosphonic acid, ethylenediamine tetramethylenephosphonic acid and 2- phosphonobutane-tricarboxylic acid-1,2,4, or the water- soluble salts thereof.
- This solution is preferably adjusted to the neutral pH range where the solution is alleged to most effectively remineralize sub-surface lesions.
- U.S. Patent Nos. 4,083,955 (Grabenstetter et al) and 4,397,837 (Raaf et al) disclose a process for remineralizing demineralized enamel by the consecutive treatment of tooth surfaces with separate solutions containing calcium ions and phosphate ions.
- fluoride ions may be present in the phosphate solutions.
- By sequentially applying calcium and phosphate ions to the tooth surface high concentrations of the ions are able to penetrate into lesions in solution form, where the ions precipitate as a calcium phosphate salt when ions from the second treatment solution diffuse in. While apparently successful, this method involves the inconvenience of a plurality of sequential applications which can be time consuming.
- U.S. Patent No. 4,606,912 (Rudy et al) teaches a method of making a clear aqueous outhwash solution capable of remineralizing lesions in teeth by forming an aqueous solution containing a source of calcium ions and a chelating agent for calcium ions, causing the chelation of at least 50% of the calcium ions and subsequently adding a source of phosphate ions to the aqueous solution.
- a source of calcium ions a chelating agent for calcium ions
- remineralization may stop before the lesion is completely remineralized due to build-up of the remineralized tooth material in or on the outer layer of the tooth's surface. This build-up occurs when the rate of remineralization is too fast and prevents the diffusion of the mineral into the deeper regions of the lesion, thus thwarting the full remineralization of the tooth.
- U.S. Patent Nos. 5,037,639; 5,268,167; 5,437,857; 5,427,768; and 5,460,803 (all to Tung) involve the use of amorphous calcium compounds such as amorphous calcium phosphate (ACP) , amorphous calcium phosphate fluoride (ACPF) and amorphous calcium carbonate phosphate (ACCP) for use in remineralizing teeth.
- ACP amorphous calcium phosphate
- ACPF amorphous calcium phosphate fluoride
- ACCP amorphous calcium carbonate phosphate
- These amorphous compounds or solutions which form the amorphous compounds when applied either onto or into dental tissue prevent and/or repair dental weaknesses such as dental caries, exposed roots and dentin sensitivity.
- the compounds are claimed to have high solubilities, fast formation rates and fast conversion rates (to apatite) .
- Remineralization is accomplished by bringing the amorphous compound into contact with the dental tissue. This can be done directly, i.e., putting an amorphous compound directly on the tooth, or indirectly through a carrier, i.e., incorporating the amorphous compound in a carrier such as a gel, a chewing gum, or a toothpaste and applying the carrier to the dental tissue.
- a carrier i.e., incorporating the amorphous compound in a carrier such as a gel, a chewing gum, or a toothpaste and applying the carrier to the dental tissue.
- the amorphous calcium phosphate compounds will recrystallize to the less soluble apatite form in the lesion and reform the tooth.
- the quantity of calcium and phosphate released is relatively low and, therefore, remineralization is slower than desirable.
- the aforementioned patents to Tung also teach the use of two-part solutions wherein a first part contains phosphate salt(s) and a second part contains calcium salt(s) , wherein either the first part or the second part further contains carbonate salt(s) .
- the Tung patents teach solutions formed by dissolving in water a solid powder containing calcium salt(s) , phosphate salt(s), and carbonate salt(s) . These solutions are then applied to dental tissue.
- the Tung patents further teach the use of non-carbonated solid powders containing mixtures of calcium salts and phosphate salts which can be applied directly to the tooth or dispersed in gel, chewing gum, or other non- aqueous mediums such as toothpaste which is placed in contact with the tooth.
- the patents teach that these powders are easily dissolved in saliva and then reprecipitated as an amorphous calcium phosphate compound.
- the Tung patents do not disclose the pHs of aqueous solutions formed from the non-carbonated solid
- Effective remineralizing/mineralizing products and methods are continually desired which do not require the presence of carbonate salts to achieve stability, remineralization and/or mineralization. It is also continually desirable to provide remineralizing/mineralizing products and methods which directly form hydroxyapatite at the subsurface of the tooth rather than first forming an amorphous calcium phosphate as an intermediate. In addition, it is continually desirable to provide a remineralization product in the form of a one-part, stable remineralizing composition which is not negatively affected by a rise in pH or temperatures or which can efficiently remineralize teeth.
- the one-part and two-part products contain at least one water-soluble calcium salt, at least one water-soluble divalent metal salt wherein the divalent metal is other than calcium and at least one water-soluble phosphate salt.
- the calcium and divalent metal salts are disposed in a first discrete component
- the phosphate salt(s) is disposed in a second discrete component.
- the two-part product may further contain a dispensing means for allowing the first and second components to be simultaneously dispensed from the product to permit the dispensed first and second components to simultaneously contact the tooth or teeth being treated.
- the aqueous solution formed by mixing the salts used in the one-part and two-part products has a pH of from about 4.0 to about U.S.
- 5,605,675 discloses a two-part product and method of using same for remineralizing dental enamel, wherein the product contains a first discrete component containing at least one water-soluble calcium salt and a second discrete component containing at least one water- soluble phosphate salt and at least one water-soluble fluoride salt.
- the product may further contain a means for allowing the first and second components to be simultaneously dispensed from the product.
- the first and second components of the product each have a pH such that when the two components are mixed to form an aqueous mixed solution, the solution has a pH of from about 4.5 to about 10.0.
- U.S. 5,645,853 is directed to a chewing gum product and method of using same for remineralizing subsurface lesions in teeth, wherein the product contains a water-soluble cationic portion composed of at least one water-soluble calcium salt and at least one water- soluble, non-toxic divalent metal salt wherein the divalent metal is other than calcium; a water-soluble anionic portion containing at least one water-soluble phosphate salt; and a gum base.
- the anionic and cationic portions are disposed in the product such that chewing of the product in the presence of water and/or saliva causes the anionic and cationic portions to be simultaneously released into the water and/or saliva to form a mixed aqueous solution therewith.
- the anionic and cationic portions each have a pH when dissolved in water and/or saliva such that the mixed aqueous solution has a pH of from about 4.0 to 7.0.
- U.S. 5,571,502 is directed to one-part, non- aqueous products and methods of using same for remineralizing subsurface lesions, wherein the products contain at least one water-soluble calcium salt; at least one water-soluble phosphate salt; either a stabilizer or a hydrophilic, non-aqueous, water-soluble vehicle; and, optionally, at least one water-soluble fluoride salt.
- the components When the components are mixed with water or saliva to form an aqueous mixed solution, the solution has a pH of from about 4.5 to about 10.0.
- the cationic and anionic components are kept separate from one another until use of the product.
- the cations and anions are delivered simultaneously to the surface of the tooth being treated.
- the concentration of calcium and phosphate ions in saliva must be above the concentration required to saturate the solution with respect to the formation of calcium hydroxyapatite, octacalcium phosphate, dicalcium phosphate dihydrate, or other forms of insoluble calcium phosphate.
- these requirements are met by the levels of calcium and phosphate in normal human saliva.
- the concentration of calcium and phosphate ions in normal human saliva is only modest, even at pHs above 6.5, the rate of mineralization produced by normal saliva is very slow even when fluoride is present to catalyze the process.
- a remineralization product In addition to a product that controls the untimely precipitation of calcium and phosphate salts, it is also highly desirable for a remineralization product to release remineralization salts over an extended period of time especially in the interproximal surfaces of teeth where food particles and bacteria can lodge to cause the formation of dental caries.
- U.S. Patent No. 4,638,823 discloses a fluoride- coated dental floss which claims to have enhanced bactericidal activity.
- Stannous fluoride is coated on dental floss in a mixture of water-soluble wax such as polyethylene glycol. The fluoride is deposited on interproximal teeth surfaces during flossing to prevent bacterial growth.
- U.S. Patent No. 4,414,990 also discloses a fluoride-coated dental product.
- the fluoride is coated on the dental floss in a polymeric coating in contrast to a wax coating.
- the polymeric coating is water soluble. During flossing the polymeric coating dissolves releasing the fluoride into the interproximal spaces and subgingival surfaces of teeth to hinder bacterial growth.
- solid products for depositing fluoride onto teeth to hinder bacterial growth to prevent the formation of dental caries such solid products do not provide for the release of calcium and phosphate salts into the of teeth for the remineralization of teeth or the mineralization of dentin tubules.
- a primary object of the present invention is to provide solid products and methods for the remineralization and the prevention of demineralization of human teeth, where the solid products and methods are capable of effectively incorporating calcium ions, phosphate ions and, if present, fluoride ions into the subsurface of a tooth.
- a further object of the present invention is to provide products and methods for the remineralization and the prevention of demineralization of human teeth, where the precipitation of the calcium, phosphate and, if present, fluoride ions is substantially avoided prior to diffusion of the ions into the subsurface of a tooth without reducing the rate of remineralization at the subsurface of the tooth.
- Still another object of the present invention is to provide solid products for the remineralization and the prevention of demineralization of human teeth, wherein the solid products are easily usable by the consumer and do not differ significantly, in flavor or appearance, from customary dental cosmetics.
- Yet another object of the present invention is to provide an improved solid product and a method of preparing such solid product, where the solid product is maintainable in a single container, substrate or matrix and is capable of remineralizing lesions in the teeth and mineralizing normal teeth to prevent cariogenic lesions from forming therein.
- a further object of the present invention is to provide remineralizing/mineralizing solid products and methods which can directly form hydroxyapatite in the subsurface of a tooth subsurface without first forming an amorphous calcium phosphate as an intermediate.
- a further object of the present invention is to provide for products and methods for the extended release of remineralization salts into the interproximal and subgingival surfaces of teeth to prevent dental caries.
- the present invention provides effective remineralizing/mineralizing solid products and methods of using same which overcome the aforementioned problems and achieve the foregoing objects.
- the present invention provides solid products for remineralizing subsurface lesions and/or mineralizing exposed dentin tubules in teeth, containing:
- the solid product is capable of simultaneously releasing the components of part (a) and the components of part (b) from (c) the carrier component into water and/or saliva when the product is contacted or mixed with the water and/or saliva.
- Remineralization and/or mineralization is effected by contacting or mixing the above-described solid product with water and/or saliva such that the solid product releases components (a) and (b) from carrier component (c) into the water and/or saliva to form a mixed aqueous composition, and then applying the mixed aqueous composition to at least one surface of at least one tooth for a period of time sufficient to allow the dissolved calcium cations and the dissolved phosphate anions to diffuse through the surface of the tooth to the subsurface and/or onto or into the dentin tubules, wherein the diffused cations and anions precipitate to form an insoluble compound on the subsurface lesion and/or onto or into the exposed dentin tubules, thereby remineralizing such lesion and/or mineralizing such exposed tubules.
- the dissolved calcium cations and the dissolved phosphate anions in the aqueous composition do not immediately precipitate but rather diffuse through the surface of the tooth to the subsurface and/or onto or into dentin tubules thereof, where the ions then precipitate to form an insoluble compound on the de ineralized subsurface lesion (s) and/or onto or into the exposed dentin tubule (s).
- the solid products of the present invention also permit the placement of the remineralization salts at specific sites on a tooth or teeth that are especially susceptible to the formation of dental caries such as on the interproximal surfaces, at places close to the gum line or the subgingival surfaces where many periodontopathogens and cariogenic bacteria reside.
- the solid products of the present invention may assist in removing plaque and entrapped food particles helping to reduce the formation of dental caries, the tendency toward gingivitis and mouth odor as well as generally improving oral hygiene.
- the solid products of the present invention provide for an extended release of remineralization salts at sites which may be especially susceptible to the formation of dental caries.
- the solid products of the present invention provide for a means for remineralizing teeth and/or mineralizing dentin tubules at desired specific sites and at the same time provide an extended release of calcium and phosphate salts from the solid product.
- the methods of the present invention overcome the disadvantages of the methods discussed hereinabove in that the methods of this invention effect subsurface remineralization rather than surface remineralization. Since dental caries often begins as a subsurface demineralization of the dental enamel, subsurface remineralization arrests and repairs the carious lesion before any permanent structural damage to the tooth occurs. Furthermore, the methods of the present invention do not require preparation of the enamel surface, capping of the tooth, or removal of decay products .
- the present invention is directed to solid products and methods of using same to remineralize subsurface lesions in teeth and/or to mineralize exposed tubules in dentin.
- solid product refers to a product having a hard consistency and which can be placed in the oral cavity.
- solid products include, but are not limited to dental floss, dental tape, tooth picks, dental adhesives, implants and the like.
- the solid products of the present invention contain (a) a cationic component of at least one calcium salt; (b) an anionic component of at least one phosphate salt; (c) a carrier component for retaining part (a) and part (b) in the product such that the components of parts (a) and (b) do not prematurely react and (d) a solid substrate onto which components (a) , (b) and (c) adhere to a surface of the solid substrate.
- the cationic (a) and the anionic (b) components are preferably rapidly and simultaneously released into water and/or saliva such that the calcium and phosphate salts penetrate the subsurface of tooth enamel and dentin tubules before the precipitation of water-insoluble calcium phosphate to remineralize subsurface lesions and/or mineralize exposed dentin tubules in teeth.
- the solid products of the present invention provides for water soluble or partially water soluble calcium and phosphate ions such that the ions penetrate the subsurface of tooth enamel and dentin tubules without an untimely precipitation of calcium phosphate.
- the solid products advantageously provide for a means of depositing the remineralization salts at or near specific sites on a tooth (teeth) where mineralization or remineralization may be especially needed.
- the solid products can readily deposit remineralization salts for extended release on the interproximal surfaces, at places close to the gum line or on the subgingival surfaces of teeth where periodontopathogens in combination with cariogenic bacteria may thrive and cause dental caries. Such surfaces of teeth are difficult to clean thus prone to the formation of cavities.
- the components (a) and (b) have a pH in water such that a mixed aqueous composition formed by mixing components (a) and (b) with water and/or saliva has a pH of from about 4.0 to about 10.0.
- the pH is from about 4.5 to about 6.5, and most preferably from about 5.00 to about 5.75.
- high concentrations of the calcium cations, and phosphate anions in the mixed aqueous composition remain soluble for a period of time sufficient to allow the ions to diffuse through the surface of the tooth to the subsurface of the enamel and/or on the dentin thereof.
- the mixed aqueous composition has a pH below about 3, de ineralizing will occur rapidly. A pH below about 2.5 is undesirable from a safety standpoint. Such acidic pHs can damage or irritate the tissue of the oral cavity.
- components (a) and (b) of the products form a pH in water and/or saliva such that the mixed aqueous composition formed therefrom has a pH within the aforementioned ranges.
- at least one or more water-soluble salt of a divalent metal other than calcium may be included.
- the products may further contain at least one water-soluble fluoride salt.
- the term "water-soluble" with respect to the calcium salt(s) component refers to any toxicologically harmless calcium salt at a pH where the calcium salt is capable of releasing more calcium ions than CaHP0 4 ' 2H 2 0 at pH 7.0.
- the solid products of the present invention for the remineralization of enamel and/or dentin tubules release to the saliva in the local areas of application at least about 100 ppm, preferably, at least about 1000 ppm of calcium ions to the water and/or saliva, the upper limit is about 35,000 ppm of calcium ions.
- the anionic salt(s) of the solid products contains at least one water-soluble or partially water soluble phosphate salt in an amount such that the mixed aqueous and/or saliva composition in the local area of application will contain dissolved phosphate anions.
- the mixed aqueous composition will preferably contain at least about 100 ppm, more preferably from about 500 ppm to about 40,000 ppm, of the dissolved phosphate anions. A portion of the phosphate salt may be present in the mixed aqueous composition as undissolved phosphate salt.
- water-soluble as used herein with respect to the phosphate, fluoride and divalent metal salts suitable for use in the present invention refers to a solubility such that the salts are each capable of having a solubility in water of at least about 0.25 gm in 100 ml of water at about 20°C.
- the products may further contain one or more non-toxic, water-soluble or partially water soluble salt of a divalent metal other than calcium.
- the solid product contains an amount of the divalent metal salt such that the mixed aqueous and/or saliva composition contains dissolved divalent metal cations.
- the presence of such dissolved divalent metal cations in the mixed aqueous composition may help to stabilize the composition in the local area of application against premature precipitation of the calcium cations and the phosphate anions to help in allowing the remineralizing cations and anions to diffuse through the tooth surface to the subsurface lesion (s) and/or exposed dentin tubule(s) prior to precipitating.
- the mixed aqueous composition in the local areas of application may contain from about 100 ppm, more preferably from about 500 ppm to about 40,000 ppm, of the dissolved divalent metal cations.
- the products may further contain at least one water-soluble fluoride salt, the caries-prophylactic activity of which has long been established.
- at least one water-soluble fluoride salt the caries-prophylactic activity of which has long been established.
- high levels of such fluoride salt(s) in the products are undesirable.
- the total quantity of fluoride applied is such as to limit ingestion and/or absorption of fluoride to no more than about l mg per use and preferably to less than about 0.1 mg.
- Low concentrations of fluoride anions can be useful in the mixed aqueous compositions in the local areas where the products are applied. Such local low concentration levels of fluoride anions preferably range from about 1 ppm to about 2000 ppm.
- Suitable fluoride salts for use in the present invention include the alkali fluorides such as sodium, potassium, lithium or ammonium fluoride; tin fluoride; indium fluoride; zirconium fluoride; copper fluoride; nickel fluoride; palladium fluoride; fluorozirconates such as sodium, potassium or ammonium fluorozirconate or tin fluorozirconate; fluorosilicates; fluoroborates; and fluorostannites.
- Organic fluorides such as the known amine fluorides, are also suitable for use in the products of the present invention.
- Water-soluble alkali metal monofluoro- phosphates such as sodium monofluorophosphate, lithium monofluorophosphate and potassium monofluorophosphate, (the sodium monofluorophosphate being preferred) may be employed.
- other water-soluble monofluorophosphate salts may be employed, including, for example, ammonium monofluorophosphate, aluminum monofluorophosphate, and the like.
- the solid products of the present invention provide from about 0.01% to about 15.0%, preferably from about 0.10% to about 10.0%, by weight of the water- soluble or partially water soluble calcium salt.
- the solid products may further provide 0.001%, more preferably from about 0.0001% to about 2.0%, and most preferably from about 0.01% to about 1.0%, by weight of the divalent metal salt(s) other than calcium as previously discussed herein.
- the products of the present invention contain from about 0.01% to about 15.0%, preferably from about 0.10% to about 10.0%, by weight of the water-soluble or partially water soluble phosphate salt(s) .
- the solid product may further contain up to about 5000 ppm, more preferably from about 1 to 1000 ppm of fluoride ion.
- the products of the present invention contain a molar ratio of the calcium salt(s) to the phosphate salt(s) of from about 0.01:1 to about 100:1.
- concentration of the calcium salt(s) and the concentration of the phosphate salt(s) are in the range of about 5:3 to about 1:1 in the products.
- Any suitable water-soluble or partially water soluble calcium salt can be employed to practice the present invention.
- Preferred water-soluble calcium salts include, but are not limited to, calcium acetate, calcium lactate, calcium chloride, calcium gluconate, calcium glycerophosphate, calcium nitrate, monocalcium orthophosphate, i.e., Ca(H 2 P0 4 ) 2 »H 2 0 and the like.
- Calcium salts which are normally insoluble at neutral or alkaline pHs can be used if an acidic component is present to increase solubility.
- Such water- insoluble calcium salts include, but are not limited to, calcium phosphate such as dicalcium phosphate, calcium hydroxyapatite and the like.
- acidic material may be added to the product to ensure the solubility of the calcium salts in the water and/or saliva.
- Any acid compound suitable for maintaining the solubility of calcium salts can be employed. Specific examples of such acid compounds are discussed below.
- Calcium salts of partial water-solubility that can be used to practice the present invention include, but are not limited to, calcium sulfate, anhydrous calcium sulfate, calcium sulfate hemihydrate, calcium sulfate dihydrate, calcium malate, calcium tartrate, calcium malonate, calcium succinate, and mixtures of the foregoing. Calcium sulfate is the preferred partially water-soluble calcium salt.
- the term "partially water- soluble" with respect to the calcium salt component refers to any toxicologically harmless calcium salt having a solubility in water which is greater than that of dicalcium phosphate dihydrate in an aqueous solution having a pH of about 7.0 and a temperature of about 25°C but which is less than that solubility which would release more than about 1400 ppm of calcium cations in such aqueous solution.
- diacalcium phosphate dihydrate In an aqueous solution having a pH of about 7.0, diacalcium phosphate dihydrate generally releases about 40 ppm of calcium cations.
- the partially water-soluble calcium salt(s) used in the present invention generally has a solubility in water such that the salt releases more than about 40 ppm but no more than about 1400 ppm of calcium cations in an aqueous solution having a pH of about 7.0 at a temperature of about 25°C.
- the partially water-soluble calcium salt(s) used in this invention has a solubility in water such that the salt(s) releases from about 100 ppm to no more than about 1400 ppm of calcium in such aqueous solution.
- the principle known as the "common ion effect" also can be used to control the solubility of the partially water-soluble calcium salt(s) used and to optimize calcium release and fluoride stability.
- a water- soluble "common anion” salt can be added to the products wherein the anion of the salt is the same as the anion present in the calcium salt employed.
- the preferred "common anion” salts are the sodium, potassium and ammonium salts.
- an anion which is part of another functional ingredient may also be added.
- the use of magnesium sulfate in a calcium sulfate-based formulation can supply at least some of the needed sulfate anion.
- any water-soluble inorganic orthophosphate salt(s) can be used to practice the present invention.
- Such orthophosphate salts include, but are not limited to, alkali salts and ammonium salts of orthophosphoric acid such as potassium, sodium or ammonium orthophosphate; monopotassium phosphate; dipotassium phosphate; tripotassium phosphate; monosodium phosphate; disodium phosphate and trisodium phosphate and the like.
- Such phosphate salts may provide for an acid buffer system to provide for a suitable pH to solubilize the calcium and phosphate salts upon the release of the salts from the product into the water and/or the saliva.
- More alkaline phosphate salts can be employed to practice the present invention, however, such phosphate salts need to be combined with acidic compounds to provide for an acidic environment to solubilize the calcium and phosphate salts released from the product into water and/or saliva.
- the solid products can also include partially water-soluble phosphate such as magnesium phosphate.
- partially water-soluble with respect to the partially water-soluble phosphate compound refers to a phosphate compound having a solubility such that in an aqueous solution having a pH of about 7.0 and a temperature of about 25°C, the phosphate compound is capable of releasing more than about 40 ppm but no more than about 1400 ppm of phosphate anions, preferably from about 100 ppm to no more than about 1400 ppm of phosphate anions, by weight of the aqueous solution.
- Suitable pH-adjusting compounds i.e., acids, bases or buffers
- acids, bases or buffers can be included in the products of the present invention to assure that the mixed aqueous compositions formed therefrom will have a pH within the ranges mentioned above.
- the pH of the mixed aqueous composition in local areas where the product is applied may be controlled by adding to the product or the mixed aqueous composition any acid, base or buffer which is safe for use in the oral cavity and which yields the desired pH at the amount used.
- suitable acids include acetic acid, phosphoric acid, citric acid, gluconic acid, tartaric acid, and malic acid.
- Suitable buffers which can be used include, but are not limited to, e.g., sodium citrate, tartrate, lactate, benzoate, carbonate, bicarbonate, malate, disodium hydrogen phosphate, sodium dihydrogen phosphate and the like.
- the divalent metal compound(s) which can be used in the products of the present invention may be any water-soluble, non-toxic divalent metal compound which will help stabilize the calcium, phosphate and fluoride ions such that these ions do not rapidly or prematurely precipitate before diffusing into the teeth. In practice, however, it has been found that at least one member selected from the group consisting of magnesium, strontium, tin, and zinc, with magnesium being preferred, is the most effective divalent metal in stabilizing the system.
- Suitable magnesium compounds include, for example, magnesium acetate, magnesium ammonium sulfate, magnesium benzoate, magnesium bromide, magnesium borate, magnesium citrate, magnesium chloride, magnesium gluconate, magnesium glycerophosphate, magnesium hydroxide, magnesium iodide, magnesium oxide, magnesium propionate, magnesium D-lactate, magnesium DL-lactate, .magnesium orthophosphate, magnesium phenolsulfonate, magnesium pyrophosphate, magnesium sulfate, magnesium nitrate, and magnesium tartrate.
- Preferred magnesium compounds are magnesium chloride, magnesium acetate and magnesium oxide.
- Suitable strontium compounds include, for example, strontium acetate, strontium ammonium sulfate, strontium benzoate, strontium bromide, strontium borate, strontium caprylate, strontium carbonate, strontium citrate, strontium chloride, strontium gluconate, strontium glycerophosphate, strontium hydroxide, strontium iodide, strontium oxide, strontium propionate, strontium D-lactate, strontium DL-lactate, strontium pyrophosphate, strontium sulfate, strontium nitrate, and strontium tartrate.
- Preferred strontium are strontium acetate, strontium chloride, strontium nitrate.
- Suitable tin compounds include, for example, stannous acetate, stannous ammonium sulfate, stannous benzoate, stannous bromide, stannous borate, stannous carbonate, stannous citrate, stannous chloride, stannous gluconate, stannous glycerophosphate, stannous hydroxide, stannous iodide, stannous oxide, stannous propionate, stannous D-lactate, stannous DL-lactate, stannous orthophosphate, stannous pyrophosphate, stannous sulfate, stannous nitrate, and stannous tartrate.
- a preferred tin compound is stannous chloride.
- Suitable zinc compounds include, for example, zinc acetate, zinc ammonium sulfate, zinc benzoate, zinc bromide, zinc borate, zinc citrate, zinc chloride, zinc gluconate, zinc glycerophosphate, zinc hydroxide, zinc iodide, zinc oxide, zinc propionate, zinc D-lactate, zinc DL-lactate, zinc pyrophosphate, zinc sulfate, zinc nitrate, and zinc tartrate.
- Preferred zinc compounds are zinc acetate, zinc chloride, zinc sulfate, and zinc nitrate.
- the aqueous cationic salt may contain an amount of dissolved calcium cations released by the calcium salt and an amount of an undissolved form of the calcium salt.
- the aqueous cationic salt preferably contains no more than about 0.14% by weight, more preferably no more than about
- the aqueous cationic component preferably contains at least about 0.05%, more preferably at least about 0.20%, most preferably from about 0.20% to about 0.30%, by weight of the undissolved form of the calcium salt.
- the aqueous cationic component may further contain dissolved divalent metal cations released by the divalent metal salt.
- the aqueous cationic component may further contain dissolved ions released by the common-anion salt.
- the aqueous anionic component may contain dissolved phosphate anions released by the phosphate salt. If the anionic component further contains at least one water-soluble fluoride salt as previously discussed herein, the aqueous anionic component may further contain dissolved fluoride anions released by the fluoride salt.
- Another embodiment of the product of the present invention is a water-soluble, dry-mix product capable of being combined with a non-aqueous solid carrier medium or with an aqueous liquid medium to form a remineralizing/mineralizing product.
- Such dry-mix product contains (a) from about 1.0% to about 80.0% by weight of the water-soluble calcium salt(s) and from about 1.0% to about 80.0% by weight of the water-soluble phosphate salt(s) , and (b) from about 1.0% to about 80.0% by weight of the water-soluble alkaline salt(s).
- the components can be encapsulated as discussed below. However, if the materials are in an anhydrous form such materials need not be encapsulated.
- the dry mix product of the present invention further contains from about 0.1% to about 20.0% by weight of the divalent metal salt(s) discussed previously herein.
- the dry mix product may also contain up to about 0.01% by weight of the fluoride salt(s) discussed hereinabove.
- the dry-mix product may be mixed with a solid carrier medium such as a water- soluble wax.
- the carrier component of the solid products of the present invention can be any suitable gum, starch, wax or polymeric material which can release the calcium and phosphate salts, preferably simultaneously, into the water and/or saliva and which also can be readily coated on a surface of a solid substrate of the solid product.
- suitable gums and starches include, but are not limited to, gum acacia, gum arabic, gum tragacanth and the like; starches such as corn starch, dextrins and the like can be employed.
- the preferred waxes for coating the solid substrate are those that are white or colorless, are relatively soft and have a melting point of from about 140°F to about 300°F.
- Such waxes include, but are not limited to, beeswax, paraffin and microcrystalline waxes or mixtures thereof.
- Most preferred waxes are non- hygroscopic but water soluble or easily water dispersable so as to prevent reaction of the salts prior to use, but which rapidly release the salts when applied.
- Such waxes include, but are not limited to polyethylene glycols such as those sold under the trademark "Carbowax" by Union Carbide Corp., New York, and the like as well as mixtures thereof.
- Such most preferred waxes also include polyoxyethylene or polyoxypropylene or mixed block copolymers of ethylene oxide and propylene oxide.
- polymers are the "Pluronics” sold by BASF.
- Pluronic® F127 An example of such "Pluronics” is Pluronic® F127.
- the wax comprises about 2% to about 30% by weight of the solid product, preferably about 10% to about 25% by weight.
- the wax portion of the solid product can carry flavor oils spray dried into suitable water-soluble carriers. These flavors are then included in the wax during the manufacture of the solid product according to methods known to those familiar with the art. Upon use, the water present in the oral fluids releases the flavor.
- the present invention also utilizes other polymeric materials than those described above as a carrier for the remineralization salts.
- Such polymeric coating materials preferably have good adhesion, clarity, toughness, and are non-toxic.
- the polymeric material be a film former such that a uniform continuous coating on the substrate can be achieved.
- the polymeric material be capable of hydration whereby the film formed is water pervious allowing for rapid and simultaneous release of calcium and phosphate salts therefrom. Hydration means the mechanism by which the polymeric material absorbs and combines with water.
- the substrate When such polymeric coatings are employed, it is preferable to first coat the substrate with a layer of wax to ensure adhesion of the polymer to the substrate. Good adhesion of the polymeric coating to the wax layer or coating of the substrate is important to ensure composition integrity such that the remineralization salts incorporated into the polymeric coating adhere to the substrate. Clarity of the coating is desirable to allow dyes applied to the substrate to be visible, and thus allow more aesthetic flexibility.
- the polymeric coating preferably is sufficiently tough to resist abrasion of the substrate to prevent cracking or flaking and resultant loss of the remineralization salts before placement of the solid product in the oral cavity.
- polymeric coatings which are useful in the present invention include, but are not limited to; a. alkyl monoesters of poly(methyl vinyl ether/maleic acid) ; b. polyvinyl pyrrolidones; c. acrylamide/acrylate/butylaminoethyl methacrylate polymers. Polymers of this type are sold by National Starch & Chemical Corporation under the trademark "Amphomer” ; d. vinyl acetate/crotonic acid/vinyl neodecanoate terpolymers. Terpolymers of this type are sold by National Starch & Chemical Corporation under the trademark "Resyn 28-2930"; e. vinyl acetate/crotonic acid copolymers. Copolymers of this type are sold by the
- terpolyamides comprised of the copoly erization products of three polyamide precursors, a dicarboxylic acid- diaamine reaction product and a lactam.
- Terpolymers of this type are sold by Belding Chemical Industries as the BCI-600 series nylons; g. hydroxypropyl cellulose. Polymers of this type are sold by Hercules Incorporated under the trademark "Klucel” .
- the polymeric coating placed on the surface of the wax preferably comprises from about 1 to about 10 percent by weight of the final product.
- the polymeric coating is less than about 1 percent of the product weight it may be ineffectual in keeping sufficient calcium and phosphate salts adhered to a surface of the solid substrate. If it is more than about 10 percent of the product weight the coating may adversely affect product aesthetics.
- the salts can additionally be encapsulated in a separating component.
- Encapsulation within the context of the present invention means that the ion particles of the components can be entirely coated or only partially coated.
- the ions are encapsulated such that the cationic and anionic salts are preferably released simultaneously into the water and/or saliva.
- encapsulation of the components prevents reaction of the components with substances such as traces of water in or absorbed into the product during storage. Also, encapsulation prevents undesirable premature reaction between the cationic and anionic ions of the solid product.
- the encapsulant is edible or rinsable from the mouth.
- Suitable encapsulating or coating materials include oleophilic and other materials such as conventional edible gums, polymers which exhibit proportion ranging from hydrophilic to hydrophobic (water-insoluble) , resins, waxes and mineral oils.
- Preferred polymers for coating or encapsulating the salt particles are hydrophilic organic polymers and hydrophobic (water-insoluble) organic polymers and mixtures thereof.
- Suitable hydrophilic polymers include water- soluble and water-dispersible organic polymers.
- a mixture of polymers can be used, and from about 5.0% to about 95.0% by weight of a water-insoluble polymer can be included with the hydrophilic polymer.
- Suitable hydrophilic polymers for coating the salt particles include, e.g., gum arabic, gum karaya, gum tragacanth, guar gum, locust bean gum, xanthan gum, carrageenan, alginate salt, casein, dextran, pectin, agar, sorbitol, 2-hydroxyethyl starch, 2-aminoethyl starch, maltodextrin, amylodextrin, 2-hydroxyethyl cellulose, methyl cellulose, carboxymethyl cellulose salt, cellulose sulfate salt, polyvinylpyrrolidone, polyethylene glycol, polypropylene glycol, polyethylene oxide, polyvinyl alcohol/acetate, and the like.
- Polyvinyl acetate is an example of a water-insoluble polymer which can be included as an additional coating component to moderate the hydrophilicity of a hydrophilic polymer coating.
- Suitable water-insoluble polymers in combination with one or more other components, for coating the salt particles in the present invention include polyvinyl acetate, polyacrylamide, polyvinylchloride, polystyrene, polyethylene, polyurethane, and the like.
- the polymer coating can be applied to the cations and anions of the components by conventional means such as pan coating, fluidized coating, centrifugal fluidized coating, and the like.
- the coating polymer is usually dissolved in a suitable solvent such as water, methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethylformamide and the like, as appropriate for a selected polymer species.
- a coating polymer can also be applied in the form of an emulsion or suspension. After the coating medium is applied to the particles, the solvent medium is removed by evaporation, thereby forming a continuous film coating which encapsulates the discrete particles.
- the film coating thickness on the surface of the encapsulated component preferably ranges from about 0.1 to about 20 microns.
- the film coating can contain one layer or multiple layers, and may constitute from about 0.5% to about 50.0% of the total dry weight of the coated particles.
- the surface coating of water-insoluble polymer may contain from about 5.0% to about 30.0% by weight of a particulate water-extractable organic or inorganic filler, such as, e.g., sodium onosaccharide or disaccharide, sorbitol powder, annitol, and the like.
- a particulate water-extractable organic or inorganic filler such as, e.g., sodium onosaccharide or disaccharide, sorbitol powder, annitol, and the like.
- the rate of release of the encapsulated particles under aqueous conditions can be controlled by the quantity and type of polymer coating on the particle surface.
- Low molecular weight hydrophilic polymers will release the particle core matrix content at a relatively fast rate in the presence of moisture.
- High molecular weight polymers which are less hydrophilic will release at a relatively slow rate. Additional rate control is obtained by using mixtures of polymer components of varied hydrophilicity.
- Polyethylene glycol or polyvinyl alcohol will release the particle core matrix at a relatively fast rate.
- Polyethylene oxide or partially hydrolyzed polyvinyl acetate will release at a relatively slow rate.
- Polyvinylpyrrolidone will release the particle core matrix content at an immediate rate when the encapsulated particles incorporated into the solid product are applied to the teeth.
- suitable oleophilic coatings or encapsulating materials include paraffin; mineral oil; edible oils such as peanut oil, coconut oil, palm oil, or safflower oil; oleophilic organic esters such as isopropyl siloxane myristate or isopropyl pal itate; edible polysiloxanes; and the like.
- Encapsulating salts with a mixture of paraffin and waxes are also suitable.
- the use of mineral oil as the oleophilic coating material is particularly advantageous because mineral oil will help in removing undesired bacteria during the course of treatment of the teeth with the mixed aqueous composition formed of the solid products.
- the oleophilic coating should be thick enough that the coating will either readily dissolve, disperse, emulsify or disintegrate in water and/or saliva during chewing or sucking of the product to release the salts. If a water-insoluble oleophilic coating, e.g.
- the coating phase can be pre- emulsified with a non-ionic, non-aqueous surfactant such as a hydrophilic ethoxylated sorbitan monooleate, e.g., the material sold under the trademark Tween.
- a non-ionic, non-aqueous surfactant such as a hydrophilic ethoxylated sorbitan monooleate, e.g., the material sold under the trademark Tween.
- Other similar surfactants can be used such as sodium lauryl sulfate and other non-ionic surfactants. It is important that the encapsulant does not impede the release of the calcium cations and the phosphate anions to lead to an undesirable imbalance of cations and anions into the water and/or saliva.
- the calcium and phosphate salts can be adsorbed onto or absorbed into a material such that the salts are released from the material upon contacting the water and/or the saliva.
- suitable materials include, but are not limited to, silica, starch such as corn starch, wheat starch and potato starch and metal oxides such as titanium dioxide and alumina.
- any suitable method in the art may be employed.
- One method is to make a slurry of the components and spray them onto the particles and let the particles with the components dry.
- One advantage to incorporating the cationic and anionic components onto or into such materials is to prevent premature reaction between the components during storage which would result in the formation of an insoluble salt.
- the tooth (or teeth) are treated with the mixed aqueous composition formed from the products of the present invention as described above.
- the tooth is treated with the mixed aqueous composition for a period of time sufficient to allow the cations and the anions of the product to diffuse to the subsurface and/or dentin where the ions then precipitate an insoluble compound onto the subsurface lesion(s) and/or in the exposed dentin tubule (s) .
- the subsurface lesion (s) is remineralized and/or the exposed dentin tubule(s) is mineralized.
- the actual treatment time with products of the present invention may be brief.
- deposits of the calcium and phosphate salts on the teeth can remain for an extended period of time especially in the interproximal areas of teeth and in plaque for extended treatment of teeth.
- the ions which have diffused through the tooth surface form an insoluble precipitate in the demineralized subsurface lesion(s) and/or on the exposed dentin tubule(s) .
- the precipitate render the remineralized subsurface and/or mineralized dentin of the tooth treated in accordance with the present invention more resistant to demineralization than was the original enamel.
- the preferred precipitate is one which is less soluble than the original enamel. Tooth enamel primarily contains a slightly carbonated apatite. If the precipitating species is not carbonated, the precipitate will be somewhat less soluble than the original enamel.
- fluoride anions when fluoride anions are not present, it is desirable that conditions be present which favor the precipitation of unsubstituted hydroxyapatite. Thus, for example, it is desirable to avoid the addition of carbonates or bicarbonates to non- fluoride compositions.
- fluoride salts are used in the products of this invention, the apatite will incorporate fluoride anions, thus rendering the precipitate more resistant to demineralization than was the original enamel.
- the teeth treated with such composition will absorb more fluoride when subsequently treated with a fluoride-containing product (e.g., a fluoride toothpaste) than teeth which have not been pretreated with such composition.
- a fluoride-containing product e.g., a fluoride toothpaste
- the precipitate formed in the present invention is preferably a calcium phosphate or a hydroxyapatite.
- the products of the present invention not only remineralizes the demineralized enamel and/or mineralizes the exposed dentin tubules but also renders such remineralized enamel and/or mineralized dentin tubule more resistant to subsequent demineralization than was the original enamel or tubule.
- the mixed aqueous composition formed from the products of the present invention and the insoluble precipitate formed from the mixed aqueous composition both have acceptable levels of toxicity.
- the particular ions, in the amounts used in the remineralization and/or mineralization process are non- toxic.
- such composition and precipitate preferably be otherwise compatible in the oral environment.
- the present invention includes embodiments of the solid products that contain a stabilizing agent which helps to prevent the calcium and phosphate ions (and fluoride ions, if present) from reacting.
- a stabilizing agent may be used in place of the divalent metal salt(s) or may be used in addition to the divalent metal salt(s) .
- Suitable stabilizing agents for use include any orally acceptable material that can stabilize one or more of the calcium salt(s), phosphate salt(s) and/or fluoride salt(s) during storage of the product.
- Non-limiting examples of such stabilizing agents include desiccating agents, coating or encapsulating materials, and mixtures of the foregoing.
- Non-limiting examples of suitable desiccating agents include magnesium sulfate, sodium sulfate, calcium sulfate, calcium chloride, and colloidal silica, e.g., colloidal silica particles centered together in chainlike formations having surface areas of from about 50 to about 400 square meters per gram such as materials sold under the trademark Cab-O-Sil by Cabot Corporation. Such materials stabilize the products by, for example, absorbing any existing water either present in or contacted with the composition to prevent reaction of the calcium, phosphate and/or fluoride salts.
- the stabilizing agent When used, the stabilizing agent is present in the products in an amount effective to inhibit reaction between the calcium, phosphate and/or fluoride salts during storage thereof, while allowing release of sufficient calcium, phosphate and/or fluoride ions when the product is contacted with water and/or saliva.
- the stabilizing agent is present in an amount of up to about 7.5% by weight, preferably from about 0.01% to about 5.0% by weight.
- the solid substrate of the solid product can be any suitable water-insoluble material employed to make dental floss, dental tape, tooth picks dental adhesive, dental implants and the like.
- Tooth picks are composed of wood, plastic, metal, ivory, bone and the like. Tooth picks come with single and double rounded ends. Tooth picks also come as flat and flat at one end and rounded at the other. Tooth picks within the scope of the present invention can be prepared by any method employed in the art.
- the solid substrate of the present invention can also be any water-insoluble material suitable for dental floss, dental tape, dental adhesives, dental implants, and the like. It is to be understood that the term “dental floss” hereinafter encompasses dental tape as well as any similar article.
- the dental floss, or dental tape substrate comprises a plurality of individual filaments of a substance suitable for use as a dental floss, including, for example, nylon 6 and 66, rayon, Dacron, acetate polymers, polypropylene and similar monofilament yarns as well as cotton, wool, and other staple yarns.
- the plurality of smaller fibers are combined together to form a yarn of larger size small enough to pass between closely contacting teeth.
- the yarn filaments can be colored utilizing any suitable dye such as FD&C Blue No. 1, FD&C Yellow No. 10, FD&C Green No. 3, FD&C Red No. 40, or mixtures of these or other similar dyes.
- the preferred means of combining the fibers is to twist them together to form a floss product more resistant to shredding and filament separation than would otherwise be achieved.
- Dental floss can be made with little or no twist or it can be braided as in a dental tape.
- the twist can be from 0.0 to 6.0 turns per inch, with a preferred twist of 2.0 to 4.0 turns per inch.
- the tensile strength of the finished floss should be between 5 and 25 pounds, although higher tensile strengths are acceptable. The preferred tensile strength is about 7 to 15 pounds.
- a finished yarn of less than 5 pounds will tend to break easily during use and is unacceptable for a dental floss, and a finished yarn of more than 25 pounds tensile strength offers no advantages yet is less economical to manufacture.
- the yarn may be of 200 to 2000 denier, while the preferred dental floss is of 500 to 1600 denier for proper hand feel.
- Dental adhesives included within the scope of the present invention include adhesives which can be coated on at least one surface with the gums, starches, polymers and waxes employed as separating components.
- the dental adhesives can be prepared by any suitable method employed in the art.
- the dental adhesive can be composed of materials which include, but are not limited to, monofunctional methacrylates such as methacrylic acid, lower alkyl methacrylates (e.g., where the alkyl group has 1 to 4 carbon atoms such as methyl, ethyl, n- propyl, iso-propyl, n-butyl, sec. -butyl and tert.
- tetrahydrofurfuryl methacrylate and glycidyl methacrylate.
- methacrylate monomers include polyfunctional methacrylated which have two or more methacrylate moieties per molecule.
- Dental implants which can be employed to practice the present invention include, but are not limited to ceramic materials. Such ceramic materials may include monocrystalline alumina ceramics, polycrystalline alumina ceramics, zirconium dioxide ceramics and the like.
- the water-soluble substrate of the present invention can be coated with the separating component containing the remineralization salts by any suitable method used to coat a solid substrate. Such methods may include spray coating or pan coating and the like.
- Example A nylon 6 filament is passed through a bath of melted bees wax followed by passing the nylon 6 through a chamber of refrigerated air to effect solidification of the wax.
- the coating may also be applied by passing the nylon 6 filament through a bath of the wax in solution using a suitable solvent, such as methylene chloride. After coating, the solvent is flashed off using radiant heater or high velocity hot air. If a dye and/or a flavor is to be included, the same is placed into the wax bath or solution and thus it is coated onto the filament along with the wax.
- the polymeric coating and calcium and phosphate salts may be applied in a number of ways.
- the wax-coated nylon 6 filament may pass through a solution of the polymeric coating in a volatile solvent and then, before the solvent is flashed off, the calcium and phosphate salts are dusted onto the wet floss. Once coated, the floss is passed through an oven or drying chamber to flash off the solvent.
- the solvent-wet floss having been coated with the polymeric material, is passed through the calcium and phosphate salt powders such that the tacky surface of the floss picks up the salts and helps them adhere to the surface.
- the floss is then passed through an oven or drying chamber to flash off the solvent.
- Still another method of adding the calcium and phosphate salts to the floss is by spraying the wet floss with the powders as the floss is wound on the rewind supply spool just after the coating is applied. This may cause some of the particles to be impregnated more firmly into the polymeric coating due to mechanical compression.
- Still another method of impregnating the floss with calcium and phosphate salts is the inclusion of the calcium and phosphate salts in the polymeric material solution tank.
- the slurry formed by the particles in the solution preferably are subjected to sufficient mixing to keep the particles in suspension.
- a homogeneous suspension is required to make the level of remineralization salts as uniformly distributed along the floss as possible.
- the floss is then passed through the slurry of coating and remineralization salts by means of guides or wheels.
- the floss thus coated with a layer of the wet slurry then is dried by standard means such as passing through an oven or drying chamber to flash off the solvent.
- Dental floss in accordance with the present invention exhibits a desirable surface texture. It provides excellent cleaning to the interproximal surfaces of the teeth, while delivering an effective amount of calcium and phosphate salts to the teeth of the user to remineralize the teeth and to combat dental caries.
- other arrangements and variations within the scope and spirit of the invention will occur to those skilled in the art.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15270/99A AU1527099A (en) | 1998-01-09 | 1998-11-24 | Solid products and methods for the remineralization and prevention of demineralization of teeth |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US504598A | 1998-01-09 | 1998-01-09 | |
US09/005,045 | 1998-01-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999034772A1 true WO1999034772A1 (fr) | 1999-07-15 |
Family
ID=21713867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/024529 WO1999034772A1 (fr) | 1998-01-09 | 1998-11-24 | Produits solides et procedes pour la remineralisation des dents et la prevention de leur demineralisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1527099A (fr) |
WO (1) | WO1999034772A1 (fr) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0930867A4 (fr) * | 1996-09-27 | 2001-08-22 | Enamelon Inc | Produits et procedes ameliores de remineralisation et prevention de la demineralisation des dents |
WO2004098617A3 (fr) * | 2003-05-07 | 2005-03-31 | Osteologix As | Composition a liberation controlee contenant un sel de strontium |
WO2006055327A1 (fr) * | 2004-11-16 | 2006-05-26 | 3M Innovative Properties Company | Charges dentaires et compositions incluant des sels de phosphate |
CN100350892C (zh) * | 2003-03-07 | 2007-11-28 | 日本合成化学工业株式会社 | 牙科材料用底涂剂与象牙质再生盖髓剂 |
EP1645263A4 (fr) * | 2003-07-15 | 2008-10-08 | Kao Corp | Composition pour cavite orale |
US7595342B2 (en) | 2003-05-07 | 2009-09-29 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
WO2010129309A2 (fr) | 2009-04-27 | 2010-11-11 | Premier Dental Products Compnay | Compositions microencapsulées et procédés de minéralisation tissulaire |
CN102102242A (zh) * | 2010-12-31 | 2011-06-22 | 中国科学院上海硅酸盐研究所 | 一种聚乳酸-非晶磷酸钙复合纳米纤维材料的制备方法 |
US8278368B2 (en) | 2004-11-16 | 2012-10-02 | 3M Innnovatve Properties Company | Dental fillers, methods, compositions including a caseinate |
US8609616B2 (en) | 2004-02-26 | 2013-12-17 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
US8710114B2 (en) | 2004-11-16 | 2014-04-29 | 3M Innovative Properties Company | Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof |
US8957126B2 (en) | 2004-11-16 | 2015-02-17 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
US9814657B2 (en) | 2009-04-27 | 2017-11-14 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
US10285924B2 (en) | 2014-12-10 | 2019-05-14 | Colgate-Palmolive Company | Dental floss coating composition |
US20210236693A1 (en) * | 2020-01-30 | 2021-08-05 | SDIP Innovations Pty Ltd | Bioresorbable implant with inside-out resorption for enhanced bone ingrowth and tissue integration and method of manufacturing thereof |
WO2021152504A1 (fr) * | 2020-01-30 | 2021-08-05 | 3M Innovative Properties Company | Système de distribution pour compositions aqueuses de soins bucco-dentaires contenant du fluorure |
CN116023679A (zh) * | 2022-12-01 | 2023-04-28 | 中山大学附属口腔医院 | 一种温敏性缓释钙磷抗菌纳米水凝胶及其制备方法与应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4083955A (en) * | 1975-04-02 | 1978-04-11 | The Procter & Gamble Company | Processes and compositions for remineralization of dental enamel |
US4397837A (en) * | 1972-02-02 | 1983-08-09 | Blendax-Werke R. Schneider Gmbh & Co. | Process and composition for the remineralization and prevention of demineralization of animal teeth including humans |
US5209251A (en) * | 1988-03-29 | 1993-05-11 | Colgate-Palmolive Company | Dental floss |
US5336264A (en) * | 1988-04-20 | 1994-08-09 | Norian Corporation | Situ prepared calcium phosphate composition and method |
US5460803A (en) * | 1989-05-24 | 1995-10-24 | American Dental Association Health Foundation | Methods and compositions for mineralizing and fluoridating calcified tissues |
US5571502A (en) * | 1995-08-08 | 1996-11-05 | Enamelon Research | Stable single-part compositions and the use thereof for remineralization of lesions in teeth |
US5645853A (en) * | 1995-08-08 | 1997-07-08 | Enamelon Inc. | Chewing gum compositions and the use thereof for remineralization of lesions in teeth |
-
1998
- 1998-11-24 AU AU15270/99A patent/AU1527099A/en not_active Abandoned
- 1998-11-24 WO PCT/US1998/024529 patent/WO1999034772A1/fr active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4397837A (en) * | 1972-02-02 | 1983-08-09 | Blendax-Werke R. Schneider Gmbh & Co. | Process and composition for the remineralization and prevention of demineralization of animal teeth including humans |
US4083955A (en) * | 1975-04-02 | 1978-04-11 | The Procter & Gamble Company | Processes and compositions for remineralization of dental enamel |
US5209251A (en) * | 1988-03-29 | 1993-05-11 | Colgate-Palmolive Company | Dental floss |
US5336264A (en) * | 1988-04-20 | 1994-08-09 | Norian Corporation | Situ prepared calcium phosphate composition and method |
US5460803A (en) * | 1989-05-24 | 1995-10-24 | American Dental Association Health Foundation | Methods and compositions for mineralizing and fluoridating calcified tissues |
US5571502A (en) * | 1995-08-08 | 1996-11-05 | Enamelon Research | Stable single-part compositions and the use thereof for remineralization of lesions in teeth |
US5614175A (en) * | 1995-08-08 | 1997-03-25 | Enamelon Inc. | Stable single-part compositions and the use thereof for remineralization of lesions in teeth |
US5645853A (en) * | 1995-08-08 | 1997-07-08 | Enamelon Inc. | Chewing gum compositions and the use thereof for remineralization of lesions in teeth |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0930867A4 (fr) * | 1996-09-27 | 2001-08-22 | Enamelon Inc | Produits et procedes ameliores de remineralisation et prevention de la demineralisation des dents |
CN100350892C (zh) * | 2003-03-07 | 2007-11-28 | 日本合成化学工业株式会社 | 牙科材料用底涂剂与象牙质再生盖髓剂 |
AU2010249227B2 (en) * | 2003-05-07 | 2011-06-30 | Osteologix A/S | Controlled release composition containing a strontium salt |
WO2004098617A3 (fr) * | 2003-05-07 | 2005-03-31 | Osteologix As | Composition a liberation controlee contenant un sel de strontium |
US7595342B2 (en) | 2003-05-07 | 2009-09-29 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
AU2004237437B2 (en) * | 2003-05-07 | 2011-01-20 | Osteologix A/S | Controlled release composition containing a strontium salt |
EP1645263A4 (fr) * | 2003-07-15 | 2008-10-08 | Kao Corp | Composition pour cavite orale |
US8557224B2 (en) | 2003-07-15 | 2013-10-15 | Kao Corporation | Oral cavity composition |
US8609616B2 (en) | 2004-02-26 | 2013-12-17 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
US9517186B2 (en) | 2004-11-16 | 2016-12-13 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
US9414995B2 (en) | 2004-11-16 | 2016-08-16 | 3M Innovative Properties Company | Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof |
AU2005306867B2 (en) * | 2004-11-16 | 2011-09-08 | 3M Innovative Properties Company | Dental fillers and compositions including phosphate salts |
US8278368B2 (en) | 2004-11-16 | 2012-10-02 | 3M Innnovatve Properties Company | Dental fillers, methods, compositions including a caseinate |
KR101277869B1 (ko) * | 2004-11-16 | 2013-07-30 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 포스페이트 염을 포함하는 치과용 충전제 및 조성물 |
US10137061B2 (en) | 2004-11-16 | 2018-11-27 | 3M Innovative Properties Company | Dental fillers and compositions including phosphate salts |
JP2008520566A (ja) * | 2004-11-16 | 2008-06-19 | スリーエム イノベイティブ プロパティズ カンパニー | リン酸塩を含む歯科用充填剤および組成物 |
US8710114B2 (en) | 2004-11-16 | 2014-04-29 | 3M Innovative Properties Company | Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof |
US8957126B2 (en) | 2004-11-16 | 2015-02-17 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
WO2006055327A1 (fr) * | 2004-11-16 | 2006-05-26 | 3M Innovative Properties Company | Charges dentaires et compositions incluant des sels de phosphate |
US9233054B2 (en) | 2004-11-16 | 2016-01-12 | 3M Innovative Properties Company | Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof |
EP2424488A4 (fr) * | 2009-04-27 | 2015-04-01 | Premier Dental Products Co | Compositions microencapsulées et procédés de minéralisation tissulaire |
US9814657B2 (en) | 2009-04-27 | 2017-11-14 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
WO2010129309A2 (fr) | 2009-04-27 | 2010-11-11 | Premier Dental Products Compnay | Compositions microencapsulées et procédés de minéralisation tissulaire |
CN102102242A (zh) * | 2010-12-31 | 2011-06-22 | 中国科学院上海硅酸盐研究所 | 一种聚乳酸-非晶磷酸钙复合纳米纤维材料的制备方法 |
US10285924B2 (en) | 2014-12-10 | 2019-05-14 | Colgate-Palmolive Company | Dental floss coating composition |
US20210236693A1 (en) * | 2020-01-30 | 2021-08-05 | SDIP Innovations Pty Ltd | Bioresorbable implant with inside-out resorption for enhanced bone ingrowth and tissue integration and method of manufacturing thereof |
WO2021152504A1 (fr) * | 2020-01-30 | 2021-08-05 | 3M Innovative Properties Company | Système de distribution pour compositions aqueuses de soins bucco-dentaires contenant du fluorure |
US12246111B2 (en) * | 2020-01-30 | 2025-03-11 | SDIP Innovations Pty Ltd | Bioresorbable implant with inside-out resorption for enhanced bone ingrowth and tissue integration and method of manufacturing thereof |
CN116023679A (zh) * | 2022-12-01 | 2023-04-28 | 中山大学附属口腔医院 | 一种温敏性缓释钙磷抗菌纳米水凝胶及其制备方法与应用 |
CN116023679B (zh) * | 2022-12-01 | 2024-04-23 | 中山大学附属口腔医院 | 一种温敏性缓释钙磷抗菌纳米水凝胶及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
AU1527099A (en) | 1999-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI83035C (fi) | Tandvaordskompositioner. | |
WO1999034772A1 (fr) | Produits solides et procedes pour la remineralisation des dents et la prevention de leur demineralisation | |
US5571502A (en) | Stable single-part compositions and the use thereof for remineralization of lesions in teeth | |
US5858333A (en) | Two-part oral products and methods of using same to remineralize teeth | |
US6159448A (en) | Products and methods for the remineralization and prevention of demineralization of teeth | |
EP1073408B1 (fr) | Dentifrice de desensibilisation contenant des sels de potassium et d'etain | |
US6036944A (en) | Processes for the remineralization and mineralization of teeth | |
US4414990A (en) | Fluoridated dental articles | |
US5833957A (en) | Processes and compositions for the remineralization of teeth | |
US4980154A (en) | Tooth and gum dentifrice composition and method of making same | |
US5817296A (en) | Processes and compositions for the remineralization of teeth | |
US6159449A (en) | Dentifrice products and methods for remineralizing and/or mineralizing teeth | |
CA2499693A1 (fr) | Dentifrice a deux composants pour le blanchiment des dents | |
US6485708B1 (en) | Products and methods for the remineralization and prevention of demineralization of teeth | |
RU2739381C1 (ru) | Композиции для ухода за полостью рта | |
CA2221516A1 (fr) | Methode de fabrication d'un dentifrice pour lutter contre le tartre contenant du fluorure et du peroxyde | |
CA2171639C (fr) | Rince-bouche, dentifrice et gomme a macher renfermant du sel de calcium et un fluorure | |
JPH11130643A (ja) | 口腔用組成物 | |
CA3181968A1 (fr) | Bande ou film pour blanchiment des dents et sensibilite des dents | |
WO2024104743A1 (fr) | Composition de soins buccodentaires | |
EP4417182A1 (fr) | Composition de soin buccal | |
CA1118361A (fr) | Complexe de polycarboxylate de magnesium utilise contre le tartre dentaire | |
WO2021047971A1 (fr) | Procédé de reminéralisation et/ou de réduction de la sensibilité des dents | |
JPH0796490B2 (ja) | 歯磨組成物 | |
JPH029562B2 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |